| __timestamp | Merck & Co., Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7180000000 | 293000 |
| Thursday, January 1, 2015 | 6704000000 | 1002000 |
| Friday, January 1, 2016 | 7194000000 | 888000 |
| Sunday, January 1, 2017 | 9982000000 | 19623000 |
| Monday, January 1, 2018 | 9752000000 | 30421000 |
| Tuesday, January 1, 2019 | 9872000000 | 34794000 |
| Wednesday, January 1, 2020 | 13397000000 | 28304000 |
| Friday, January 1, 2021 | 12245000000 | 56886000 |
| Saturday, January 1, 2022 | 13548000000 | 100894000 |
| Sunday, January 1, 2023 | 30531000000 | 159765000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, Merck & Co., Inc. has consistently demonstrated its commitment to R&D, with expenditures peaking at an impressive $30.5 billion in 2023. This represents a staggering 325% increase from 2014. In contrast, Viridian Therapeutics, Inc., a smaller player, has shown a remarkable growth trajectory, with R&D spending surging from a modest $293,000 in 2014 to $159.8 million in 2023, marking an exponential increase of over 54,000%. This stark contrast highlights the diverse strategies and scales of investment between established giants and emerging innovators. As the pharmaceutical industry continues to advance, these investments underscore the critical role of R&D in driving future breakthroughs and maintaining competitive advantage.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Merck & Co., Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Investment: Merck & Co., Inc. vs Evotec SE
Merck & Co., Inc. or MiMedx Group, Inc.: Who Invests More in Innovation?
Novartis AG vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.